Suppr超能文献

分析ISDR、PKR结合域和V3区的序列构型,以预测慢性丙型肝炎感染患者对干扰素-α和利巴韦林诱导治疗的反应。

Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection.

作者信息

Murphy Melissa D, Rosen Hugo R, Marousek Gail I, Chou Sunwen

机构信息

Medical and Research Services, Portland VA Medical Center, Oregon 97201, USA.

出版信息

Dig Dis Sci. 2002 Jun;47(6):1195-205. doi: 10.1023/a:1015349924116.

Abstract

Interferon (IFN) and ribavirin combination therapy for chronic hepatitis C virus (HCV) infection yields a sustained response rate of only approximately 40%. Previous studies have linked IFN responsiveness to viral sequence variation in parts of the E2 and NS5A genes, but this remains controversial. We studied pretreatment sera from 28 subjects (23 with HCV genotype 1a) who received high-dose IFN induction followed by IFN-ribavirin combination therapy. Serum HCV sequences were amplified and compared from 14 responders with undetectable HCV RNA 24 weeks after therapy and 11 nonresponders (excluding three who dropped out of the study). Analysis included the E2 PKR eIF-2alpha phosphorylation homology domain (PePHD, codons 659-670), where the sequence was well conserved, and codons 2001-2420 of NS5A. In NS5A, the proposed PKR binding domain (codons 2209-2274), containing the putative IFN sensitivity determining region (ISDR, codons 2209-2248), showed too little variation among subjects to differentiate responders and nonresponders. NS5A codons 2356-2385 (which includes the V3 region) exhibited more variation. Here, six of 12 genotype 1a responders showed four or more amino acid changes from the prototype HCV-1 sequence, as compared with one of eight nonresponders, but this fell short of statistical significance (P = 0.16). NS5A sequences from posttreatment sera were examined in six nonresponders to look for selection of treatment-resistant viral subpopulations, but no consistent change was detected. In conclusion, our results indicate that the sequences of the ISDR, the PKR-binding domain, and the PePHD are unlikely to have predictive value for IFN treatment success in those infected with HCV genotype 1a. However, the finding of greater variability among treatment responders in the carboxy end of NS5A suggests that the V3 region merits further investigation.

摘要

干扰素(IFN)与利巴韦林联合治疗慢性丙型肝炎病毒(HCV)感染的持续应答率仅约为40%。既往研究已将IFN反应性与E2和NS5A基因部分区域的病毒序列变异联系起来,但这仍存在争议。我们研究了28名受试者(23名HCV基因1a型感染者)治疗前的血清,这些受试者接受了高剂量IFN诱导治疗,随后接受IFN - 利巴韦林联合治疗。对治疗24周后HCV RNA检测不到的14名应答者和11名无应答者(不包括3名退出研究的受试者)的血清HCV序列进行了扩增和比较。分析包括E2的PKR eIF - 2α磷酸化同源结构域(PePHD,密码子659 - 670),该区域序列保守,以及NS5A的密码子2001 - 2420。在NS5A中,拟议的PKR结合结构域(密码子2209 - 2274),包含假定的IFN敏感性决定区域(ISDR,密码子2209 - 2248),受试者之间的变异太小,无法区分应答者和无应答者。NS5A密码子2356 - 2385(包括V3区域)表现出更多变异。在此,12名基因1a型应答者中有6名与原型HCV - 1序列相比有4个或更多氨基酸变化,而8名无应答者中有1名,但其差异未达到统计学显著性(P = 0.16)。对6名无应答者治疗后血清的NS5A序列进行了检测,以寻找耐药病毒亚群的选择情况,但未检测到一致的变化。总之,我们的结果表明,对于HCV基因1a型感染者,ISDR、PKR结合结构域和PePHD的序列不太可能对IFN治疗成功具有预测价值。然而,在NS5A羧基末端治疗应答者中发现更大变异性这一结果表明,V3区域值得进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验